1162 related articles for article (PubMed ID: 11607796)
1. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up.
Saadeh AM; Jones JV
J Hum Hypertens; 2001 Oct; 15(10):677-80. PubMed ID: 11607796
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of ventricular arrhythmia in hypertensive patients].
Galinier M; Balanescu S; Fourcade J; Dorobantu M; Massabuau P; Dongay B; Cabrol P; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1049-53. PubMed ID: 9404407
[TBL] [Abstract][Full Text] [Related]
3. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
[TBL] [Abstract][Full Text] [Related]
4. QTc dispersion and complex ventricular arrhythmias in untreated newly presenting hypertensive patients.
Saadeh A; Evans S; James M; Jones J
J Hum Hypertens; 1999 Oct; 13(10):665-9. PubMed ID: 10516735
[TBL] [Abstract][Full Text] [Related]
5. QT dispersion in essential hypertension.
Clarkson PB; Naas AA; McMahon A; MacLeod C; Struthers AD; MacDonald TM
QJM; 1995 May; 88(5):327-32. PubMed ID: 7796087
[TBL] [Abstract][Full Text] [Related]
6. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
[TBL] [Abstract][Full Text] [Related]
7. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy.
Galetta F; Franzoni F; Magagna A; Femia FR; Pentimone F; Santoro G; Carpi A
Biomed Pharmacother; 2005; 59(1-2):15-9. PubMed ID: 15740930
[TBL] [Abstract][Full Text] [Related]
8. Ventricular arrhythmias in hypertension: in which patients do they occur?
Mayet J; Shahi M; Poulter NR; Sever PS; Thom SA; Foale RA
J Hypertens; 1995 Feb; 13(2):269-76. PubMed ID: 7615959
[TBL] [Abstract][Full Text] [Related]
9. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
[TBL] [Abstract][Full Text] [Related]
10. [Left ventricular hypertrophy increases the frequency of ventricular arrhythmia in hypertensive patients].
Ozdemir A; Telli HH; Temizhan A; Altunkeser BB; Ozdemir K; Alpaslan M; Karabağ T
Anadolu Kardiyol Derg; 2002 Dec; 2(4):293-9. PubMed ID: 12460824
[TBL] [Abstract][Full Text] [Related]
11. [Dispersion of QT interval in arterial hypertension with left ventricular hypertrophy].
Cavallini B; Perri V; Sali M
Minerva Cardioangiol; 1996; 44(1-2):45-8. PubMed ID: 8767622
[TBL] [Abstract][Full Text] [Related]
12. [Arrhythmic risk in essential hypertension: late potentials].
Palmiero P; Maiello M
Minerva Cardioangiol; 2004 Feb; 52(1):1-8. PubMed ID: 14765032
[TBL] [Abstract][Full Text] [Related]
13. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey.
Paoletti E; Specchia C; Di Maio G; Bellino D; Damasio B; Cassottana P; Cannella G
Nephrol Dial Transplant; 2004 Jul; 19(7):1829-34. PubMed ID: 15128888
[TBL] [Abstract][Full Text] [Related]
14. [Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor].
Schmieder RE; Messerli FH
Schweiz Med Wochenschr; 1993 Jan; 123(4):99-107. PubMed ID: 7678943
[TBL] [Abstract][Full Text] [Related]
15. [QT dispersion intervals in hypertensives with left ventricular hypertrophy].
Ghanem Wisam MA; Murín J; Jaber J; Radman A; Bulas J; Kozliková K
Vnitr Lek; 2001 Jan; 47(1):20-4. PubMed ID: 15635864
[TBL] [Abstract][Full Text] [Related]
16. QT-interval variability and autonomic control in hypertensive subjects with left ventricular hypertrophy.
Piccirillo G; Germanò G; Quaglione R; Nocco M; Lintas F; Lionetti M; Moisè A; Ragazzo M; Marigliano V; Cacciafesta M
Clin Sci (Lond); 2002 Mar; 102(3):363-71. PubMed ID: 11869178
[TBL] [Abstract][Full Text] [Related]
17. [Concentric left ventricular hypertrophy in patients with hypertension. When should ventricular hyperexcitability be searched for?].
Galinier M; Massabuau P; Puel J; Fourcade J; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1107-10. PubMed ID: 1701985
[TBL] [Abstract][Full Text] [Related]
18. Prognostic evaluation of QT-dispersion in elderly hypertensive and normotensive patients.
Dimopoulos S; Nicosia F; Turini D; Zulli R
Pacing Clin Electrophysiol; 2009 Nov; 32(11):1381-7. PubMed ID: 19712075
[TBL] [Abstract][Full Text] [Related]
19. Ventricular arrhythmias and left ventricular hypertrophy in essential hypertension.
Palmiero P; Maiello M
Minerva Cardioangiol; 2000 Dec; 48(12):427-34. PubMed ID: 11253327
[TBL] [Abstract][Full Text] [Related]
20. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
Voiculescu M; Ionescu C; Ismail G
Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
